Core Laboratories (CLB) Tops Q1 EPS by 3c; Issues Solid Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $10.33 +1.08%
Financial Fact:
Net income attributable to Core Laboratories N.V.: 16.73M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Financial Fact:
Net income attributable to Core Laboratories N.V.: 16.73M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.42, $0.03 better than the analyst estimate of $0.39. Revenue for the quarter came in at $158 million versus the consensus estimate of $150.57 million.
GUIDANCE:
Core Laboratories sees Q2 2017 EPS of $0.48-$0.52, versus the consensus of $0.48.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- QNB Corp. (QNBC) Reports Q3 Loss of $1.30
- FFB Bancorp (FFBB) Tops Q3 EPS by 161c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
